RxDoctor Payments Data

Brad Graham, MD

Dermatology · Tyler, TXNPI 1083641062

Payments from drug & device makers

$3,326in general payments, 2019–2025

Across 195 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$480
  • LEO Pharma Inc.$302
  • Sanofi$245
  • Novartis$216
  • Lilly USA, LLC$73
  • plus $288 from 11 others

What the payments were for

  • Food & beverage$3,14495%
  • Education$1825%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,326 in reported general payments places this provider in the 40th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas

Medicare billing

Part B allowed, 2024
$1,356,976
Medicare patients
11,256
Services billed
19,098

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ValacyclovirValacyclovir Hcl12$224

Paid to pharmacies, not to this prescriber.

Other dermatology in Tyler

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →